MEDICARE COVERAGE.
Cryotherapy is accessible and affordable to virtually any patient. The procedure is covered by Medicare, as well as many insurance plans and VA hospitals—not only as a primary treatment, but as a salvage option for those who have failed radiation therapy.

LESS CARE MEANS LESS COSTS.
Cryotherapy is one of the fastest growing prostate cancer treatments. It is minimally invasive, offers quick recovery and low side effects. Cryotherapy has been shown to be both clinically effective and cost effective. The procedure is typically performed on an outpatient basis. Due to outpatient treatment, recuperation periods are shorter and there are fewer complications during recovery. Thus, costs of cryotherapy are often less than those associated with many other prostate cancer treatments.